title: Therapy of rapidly progressive glomerulonephritis with immunosuppressive agents.
abstract: Rapidly progressive glomerulonephritis is a kidney disease leading to sudden and definitive damages of the renal parenchyma and progressive impairment of its function until the complete failure. Histological findings of the changes are characterized with dominant glomerular lesions with crescentic formations. Early and intensive immunosuppressive therapy with pulse doses of steroids (Solumedrol 1.5 to 2.5 g), followed by Prednisolone 1 mg/kg every other day and cytostatic drugs (cyclophosphamide 1-2 mg-kg/every other day) discontinues the processes of specific and non-specific inflammation in the kidney and could enable regeneration of the kidney tissues with favorable outcome of the disease. Immunosuppressive therapy should be gradually lowered after two months, and applied for at least three to six months.
authors.forename: M
authors.initials: M
authors.lastname: Savin
authors.forename: Lj
authors.initials: Lj
authors.lastname: Djukanović
authors.forename: M
authors.initials: M
authors.lastname: Sindjić
authors.forename: S
authors.initials: S
authors.lastname: Pavlović
authors.forename: J
authors.initials: J
authors.lastname: Dimitrijević
authors.forename: V
authors.initials: V
authors.lastname: Nestić
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology; D000293:Adolescent; D000328:Adult; D005260:Female; D005921:Glomerulonephritis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D007166:Immunosuppressive Agents